E366G (p.Glu366Gly) variant of SERPINA1 (Alpha-1-antitrypsin)
E366G (p.Glu366Gly) in SERPINA1 (Alpha-1-antitrypsin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Alpha-1-antitrypsin deficiency. The available variant effect predictions contribute to a CATVariant prioritization score of 0.65 / 1. The record also includes population frequency data, published literature, and structural context.
E366G (p.Glu366Gly) variant details
- p.Glu366Gly
- rs2504728206
- ClinGen CA390847802
- ClinVar RCV002786692
- Likely pathogenic
- Alpha-1-antitrypsin deficiency
- Missense
- Variant Prioritization Score for Impact Estimate 0.653
- REVEL 0.67
- CADD 26.00
- PolyPhen-2 1.00
- SIFT 0.00
- ClinVar: Likely pathogenic (Alpha-1-antitrypsin deficiency)
- EBI: Likely pathogenic (in A1ATD)
- UniProt: Likely pathogenic (in A1ATD)
- Most common in the Middle Eastern population (allele frequency 0.00017)
- Structural context available
- Cited in: American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of… (PMID 14522813)
- Cited in: [American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of… (PMID 15685488)